About Us

We aim to protect and preserve brain function in patients suffering from tauopathies.

Millions of people around the world are living with diseases such as progressive supranuclear palsy (PSP), Alzheimer’s disease (AD), traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE).

We are inspired by the perseverance of patients and caregivers navigating the uncertainty of these devastating neurodegenerative diseases. Their determination to fight for a better future motivates us to aggressively pursue and target toxic tau.

We are moving with focus, urgency and commitment to bring our novel therapy to these patients.

Meet Our Team

martin jefson
michael ahlijanian
larry altstiel
kim mcclure
kelly foster
Wendy Luca

Board of Directors

Scientific Advisory Board

Pinteon Therapeutics logo